Business Description
Doseology Sciences Inc
NAICS : 541720
SIC : 3741
ISIN : CA2584841043
Total Employee Number:
1Description
Doseology Sciences Inc is a diversified life sciences company, on a mission to reimagine mental health therapies through innovation, technology and sustainability. With a focus on the psychedelic and non-psychedelic compounds, also sale of its branded functional mushroom products. It offers cutting-edge therapeutic products and services, with the focus of making a meaningful impact on the mental health pandemic and improving overall health. Geographically earns it revenue from Canada.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.93 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -2.42 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 31 | |||||
3-Year EBITDA Growth Rate | 38.6 | |||||
3-Year EPS without NRI Growth Rate | 41 | |||||
3-Year FCF Growth Rate | 44.8 | |||||
3-Year Book Growth Rate | -37.5 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 14.5 | |||||
9-Day RSI | 23.99 | |||||
14-Day RSI | 29.71 | |||||
3-1 Month Momentum % | -32.81 | |||||
6-1 Month Momentum % | 500.78 | |||||
12-1 Month Momentum % | -42.51 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 10.3 | |||||
Quick Ratio | 8.46 | |||||
Cash Ratio | 4.53 | |||||
Days Inventory | 400.9 | |||||
Days Sales Outstanding | 89.22 | |||||
Days Payable | 149.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -24 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 24.69 | |||||
Operating Margin % | -1467.9 | |||||
Net Margin % | -1443.21 | |||||
EBITDA Margin % | -1467.9 | |||||
FCF Margin % | -1411.67 | |||||
OCF Margin % | -1411.67 | |||||
ROE % | -92.15 | |||||
ROA % | -86.77 | |||||
ROIC % | -266.74 | |||||
ROC (Joel Greenblatt) % | -593.51 | |||||
ROCE % | -93.56 | |||||
Moat Score | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 16.67 | |||||
PB Ratio | 1.09 | |||||
Price-to-Tangible-Book | 1.6 | |||||
EV-to-EBIT | -0.32 | |||||
EV-to-EBITDA | -0.32 | |||||
EV-to-Revenue | 4.72 | |||||
EV-to-FCF | -0.33 | |||||
Price-to-GF-Value | 0.66 | |||||
| Price-to-Net-Current-Asset-Value | 1.6 | |||||
| Price-to-Net-Cash | 3.74 | |||||
Earnings Yield (Greenblatt) % | -312.5 | |||||
FCF Yield % | -96.92 |
Doseology Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Doseology Sciences Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.1:1 Stock Split | 2024-02-16 | 0.17 (+0.00%) |
Show
Entries
Guru Commentaries on OTCPK:DOSEF
No articles.
Press Release
Articles on Doseology Sciences Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers